Short Interest in Ainos, Inc. (NASDAQ:AIMD) Increases By 107.8%

Ainos, Inc. (NASDAQ:AIMD) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totaling 23,172 shares, an increase of 107.8% from the November 30th total of 11,153 shares. Based on an average trading volume of 31,273 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.5% of the shares of the company are short sold. Currently, 0.5% of the shares of the company are short sold. Based on an average trading volume of 31,273 shares, the days-to-cover ratio is currently 0.7 days.

Insider Transactions at Ainos

In other news, major shareholder Carbon Nano Technology Taiwan sold 7,000 shares of the company’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $3.59, for a total value of $25,130.00. Following the completion of the sale, the insider directly owned 1,037,206 shares in the company, valued at $3,723,569.54. This represents a 0.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 9.79% of the company’s stock.

Institutional Trading of Ainos

A hedge fund recently bought a new stake in Ainos stock. Two Sigma Investments LP acquired a new position in shares of Ainos, Inc. (NASDAQ:AIMD) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned about 0.48% of Ainos as of its most recent filing with the SEC.

Ainos Stock Performance

Shares of Ainos stock opened at $1.95 on Friday. The business’s fifty day simple moving average is $2.57 and its 200-day simple moving average is $3.01. The company has a quick ratio of 2.67, a current ratio of 2.96 and a debt-to-equity ratio of 1.10. Ainos has a 52 week low of $1.78 and a 52 week high of $5.00. The firm has a market cap of $9.40 million, a PE ratio of -0.49 and a beta of 2.39.

Ainos (NASDAQ:AIMD) last posted its earnings results on Thursday, November 13th. The company reported ($0.64) earnings per share (EPS) for the quarter. The company had revenue of $0.00 million during the quarter.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Ainos in a research report on Monday. Wall Street Zen raised shares of Ainos from a “sell” rating to a “hold” rating in a research report on Friday, September 5th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Ainos has a consensus rating of “Sell”.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.